Search engine for other government resources

Efavirenz Emtricitabine Tenofovir Disoproxil Fumarate ...

Atripla is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children ...
clinicalinfo.hiv.gov/en/drugs/efavirenz-emtricitabine-tenofovir-disoproxil-fumarate/patient

DailyMed - ATRIPLA- efavirenz emtricitabine and ...

ATRIPLA is a prescription medicine that contains efavirenz, emtricitabine, and tenofovir disoproxil fumarate combined in 1 tablet. ATRIPLA is used ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e97aa6d-09f7-46df-9499-63db7e9bac35

PDF HIGHLIGHTS OF PRESCRIBING INFORMATION for ATRIPLA. ATRIPLA

ATRIPLA is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome, erythema ...
www.accessdata.fda.gov/drugsatfda_docs/label/2016/021937s039lbl.pdf

PDF HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights ...

ATRIPLA is a three-drug fixed-dose combination product containing 600 mg of efavirenz (EFV), 200 mg of emtricitabine (FTC), and 300 mg of tenofovir ...
www.accessdata.fda.gov/drugsatfda_docs/label/2018/021937s043lbl.pdf

PDF ATRIPLA - Food and Drug Administration

ATRIPLA is a fixed dose combination tablet containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate (tenofovir DF). SUSTIVA is the ...
www.accessdata.fda.gov/drugsatfda_docs/label/2008/021937s007lbl.pdf

PDF ATRIPLA efavirenz 600 mgemtricitabine 200 mgtenofovir ...

ATRIPLA AND ARE COINFECTED WITH HIV AND HBV. IF APPROPRIATE, INITIATION OF ANTI-HEPATITIS B THERAPY MAY BE WARRANTED (SEE WARNINGS). DESCRIPTION ATRIP ...
www.accessdata.fda.gov/drugsatfda_docs/label/2008/021937s006lbl.pdf

BFTAF vs Atripla Double-Blind Switch Study in HIV-1 ...

Atripla (ATP: FTC/TDF/EFV) was the first single pill treatment for HIV and was the most prescribed first-line treatment from approximately 2008 to ...
clinicaltrials.gov/ct2/show/NCT03532425

Discontinuation of Atripla as first-line therapy in HIV-1 ...

In individuals who discontinued Atripla data was collected on evolution of adverse events. Results: Four hundred and seventy-two individuals commenced ...
pubmed.ncbi.nlm.nih.gov/22441251/

PDF Reference ID 3846716

ATRIPLA is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome, erythema ...
www.accessdata.fda.gov/drugsatfda_docs/label/2015/021937s037lbl.pdf

Efavirenz Emtricitabine and Tenofovir MedlinePlus Drug ...

It is usually taken once a day with water on an empty stomach (at least 1 hour before or 2 hours after a meal). Take efavirenz, emtricitabine, and ...
medlineplus.gov/druginfo/meds/a616048.html

PDF HIGHLIGHTS OF PRESCRIBING INFORMATION for ATRIPLA. ATRIPLA

ATRIPLA is not approved for the treatment of chronic hepatitis B virus (HBV) infection and the safety and efficacy of ATRIPLA have not been ...
www.accessdata.fda.gov/drugsatfda_docs/label/2013/021937s027lbl.pdf

Atripla HIV therapy in one pill

Atripla is the first one-pill-daily regimen licensed for the treatment of HIV-1 infection in patients older than 18 years. H was licensed in Europe ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC2500249/

Efavirenz MedlinePlus Drug Information

you should know that efavirenz is also available in combination with another medication with the brand name of Atripla. Tell your doctor if you are ...
medlineplus.gov/druginfo/meds/a699004.html

Short Communication The Impact of Switching from Atripla ...

We investigated whether a treatment switch from Atripla (tenofovir, emtricitabine, and efavirenz) to DRV/r monotherapy may improve ...
pubmed.ncbi.nlm.nih.gov/27216134/

DailyMed - ATRIPLA- efavirenz emtricitabine and ...

ATRIPLA is a fixed-dose combination tablet containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate (tenofovir DF). SUSTIVA is the brand ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=076da359-b3d0-44f7-8c0e-662f5b7a8668

PDF Patient Information What is the most important information ...

Take ATRIPLA 1 time each day on an empty stomach. You should take ATRIPLA at the same time each day. Taking ATRIPLA at bedtime may make some side ...
rsc.niaid.nih.gov/sites/default/files/Atripla PI dated October 2019.pdf

Efavirenz C14H9ClF3NO2 - PubChem

Atripla is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil fumarate.It is indicated for the treatment of ...
pubchem.ncbi.nlm.nih.gov/compound/efavirenz

Efavirenz Emtricitabina Fumarato de disoproxilo de ...

Atripla viene en forma de tabletas. Cada tableta contiene: 600 mg de efavirenz (marca comercial: Sustiva) 200 mg de emtricitabina (marca comercial ...
clinicalinfo.hiv.gov/es/drugs/efavirenz-emtricitabina-fumarato-de-disoproxilo-de-tenofovir/paciente

EfavirenzEmtricitabineTenofovir By mouth - National ...

Efavirenz, emtricitabine, and tenofovir combination is used alone or with other anti-HIV medicines to treat human immunodeficiency virus (HIV) ...
www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010080/?report=details

Membranous Nephropathy in a Patient with Human ...

Potential nephrotoxic home medications, including Atripla and lisinopril, were held. After a brief inpatient stay, he was discharged but was ...
pubmed.ncbi.nlm.nih.gov/30931200/